Product Information

ENTECAVIR 0.5 MG TABLET is a generic product labeled by Cameron Pharmaceuticals, priced at $0.2423 per EA under NDC 42494045730. Its NADAC has been published 65 times since Aug 27, 2025.

FDA first approved this application on Dec 23, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ENTECAVIR 0.5 MG TABLET

ENTECAVIR ANHYDROUS
$0.2423per EA

Strength

.5 mg/1

NDC

42494045730

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ENTECAVIR ANHYDROUS

Approval Type

Generic (ANDA)

FDA Application

ANDA216857

FDA Approved

12/23/2024

TE Code

AB

On Market Since

5/15/2025

Pharmacological Classes

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Nucleoside Analog
Nucleoside Reverse Transcriptase Inhibitors

Price Statistics

The NADAC for ENTECAVIR 0.5 MG TABLET has been published 65 times since Aug 27, 2025, and over the history we have for it it has declined 7.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2423 per EA
All-time high$0.2640 (Oct 15, 2025)
All-time low$0.2096 (May 20, 2026)
52-week high$0.2460
52-week low$0.2096
Median price$0.2218
Average price$0.2282
Largest weekly change+12.5% (Oct 21, 2026)
Weeks tracked65
Tracking sinceAug 27, 2025

Price History

1W

-1.5%

1M

+10.8%

3M

+13.5%

6M

+15.6%

1Y

+3.3%

3Y

N/A

5Y

N/A

All

-7.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ENTECAVIR ANHYDROUS market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ENTECAVIR 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ENTECAVIR 0.5 MG TABLET, manufactured by Cameron Pharmaceuticals, is $0.2423 per EA (NDC 42494045730), effective Nov 18, 2026.

How has the price of ENTECAVIR 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for ENTECAVIR 0.5 MG TABLET has declined 7.7%. It has been tracked across 65 weekly CMS publications since Aug 27, 2025.

What are the highest and lowest recorded NADAC prices for ENTECAVIR 0.5 MG TABLET?

Since Aug 27, 2025, the NADAC for ENTECAVIR 0.5 MG TABLET has ranged from a low of $0.2096 (May 20, 2026) to a high of $0.2640 (Oct 15, 2025), with a median of $0.2218 per EA.

Are there cheaper alternatives to ENTECAVIR 0.5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of ENTECAVIR 0.5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ENTECAVIR 0.5 MG TABLET?

ENTECAVIR 0.5 MG TABLET (NDC 42494045730) is labeled by Cameron Pharmaceuticals, and CMS classifies it as a generic product.